Overview

Incidence of Hepatitis B Virus (HBV) Reactivation in HBsAg Negative/HBcAb Positive Lymphoma Patients Treated With RCHOP

Status:
Unknown status

Trial end date:
2014-08-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to identify the incidence of hepatitis B virus reactivation rate in Diffuse Large B Cell or high grade Follicular lymphoma patients with prior resolved hepatitis B undergoing RCHOP immuno-chemotherapy.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Fudan University

Treatments:

Lamivudine
Reverse Transcriptase Inhibitors